|
EP3795185A1
|
|
Bone graft material for use in a spinal fusion method
|
|
EP3536353A1
|
|
Method and kits for producing a fibrin matrix
|
|
WO2012123028A1
|
|
Pharmaceutical formulation for use in spinal fusion
|
|
EP2451492A2
|
|
Compositions for tissue augmentation
|
|
EP2227263A2
|
|
Pdgf fusion proteins incorporated into fibrin foams
|
|
CA2702190A1
|
|
Injectable radio-opaque compositions for tissue augmentation
|
|
EP2143454A1
|
|
Dispensing device, kit containing the device, and method of operating the device
|
|
WO2008132233A1
|
|
Composition, methods and kits for prevention of adhesion
|
|
CN101711168A
|
|
Polymeric tissue sealant
|
|
CN101141976A
|
|
Local treatment of bone defects with matrix releasing bmp or pth
|
|
EP1833522A2
|
|
Supplemented matrices for the repair of bone fractures
|
|
CN101098717A
|
|
Supplemented matrices for the repair of bone fractures
|
|
US2006147443A1
|
|
Synthetic biomaterials having incorporated therein bioactive factors through enzymatically degradable linkages
|
|
WO2006073711A2
|
|
Use of a matrix comprising a contrast agent in soft tissues
|
|
US2005010297A1
|
|
Balloon technologies for tissue repair
|
|
US2003232944A1
|
|
Compositions for tissue augmentation
|
